Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00279942 · ClinicalTrials.gov registry record · NA
Effect of Revival Soy on Fibromyalgia Pain
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT00279942: Completed NA study, sponsored by Mayo Clinic.
NCT00279942 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00279942, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
Fibromyalgia is characterized by widespread pain that can lead to significant patient dysfunction and economic burden to society. The management of patients with fibromyalgia is difficult and no single treatment modality has been successful. We propose to study the effect of dietary soy supplement on quality of life associated with fibromyalgia.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Soy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2006-05 |
| Est. Completion | 2006-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00279942
The ClinicalTrials.gov registry entry for NCT00279942 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00279942 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00279942 about?
NCT00279942 is a clinical study titled "Effect of Revival Soy on Fibromyalgia Pain". Fibromyalgia is characterized by widespread pain that can lead to significant patient dysfunction and economic burden to society. The management of patients with fibromyalgia is difficult and no single treatment modality has been successful. We propose to study the effect of dietary soy supplement o...
What is the current status of trial NCT00279942?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2006-05. Estimated completion is 2006-09.
What interventions are being tested in trial NCT00279942?
The interventions under investigation include: Placebo (OTHER), Soy (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00279942?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.